Some of what I know comes from conversations with people in the field so, no, there's not a written statement I can reference. But it's apparent to me that skepticism is dissipating in the medical community.
Stupp wouldn't be an author on the JAMA paper because his patients weren't part of the trial. That's standard. But after seeing the unblinded results he thinks the therapy has merit according to what I've heard from others.
Market Data 
Markets 
AI
